Boletín Mexicano de Derecho Comparado, No. 111, pp. 1011-1046, Winter 2004
36 Pages Posted: 9 Dec 2004
The pharmaceutical market in Europe, in its present circumstances, is not organized according to the principles of free trade to which other products are subjected. Under this situation, the owners of trade-marks have tried to develop price and market strategies consistent with their interests and with their commercial plans. This article (written in Spanish) examines the adjustment of conflicts of interests that have developed between protectionism and free trade within the pharmaceutical sector, which includes matters related to economic policies and legal regulation. The author analyzes the Act on Intellectual Property of the European Union and studies the rights of those who own a trade-mark, seeking to avoid the re-labeling of parallel importers.
Notes: Downloadable document is in Spanish.
Keywords: trade-marks, arbitration, free trade, protectionism, intellectual property, europoean union, paranova, bristol-myers, blister packaging
JEL Classification: O34, K10, K34
Suggested Citation: Suggested Citation
Ryan, Patrick S., Regulated Arbitrage and Parallel Importation of Trademarked Pharmaceuticals in the European Union. Boletín Mexicano de Derecho Comparado, No. 111, pp. 1011-1046, Winter 2004. Available at SSRN: https://ssrn.com/abstract=630301